How Value Analysis Committees’ Lines of Questioning Can Directly Affect Value Equation Outputs

By AHRMM

John Kelty from W.L. Gore & Associates discusses how value analysis committees can determine a medical devices value when evaluating new products. 

Related Resources

Case Studies
Leading Practice: Reduction or Elimination of CAUTI - Saint Clare's Health System
AHRMM is offering a repository for leading and proven supply chain practices, case studies, and toolkits that are developed from a
Case Studies
Leading Practice: Reduction or Elimination of CAUTI - University of Virginia Health System
AHRMM is developing a repository for leading and proven supply chain practices, case studies, and toolkits that are developed from a
Case Studies
Leading Practice: Reduction or Elimination of HAPU - Nexera
The following leading practice describes methods used to reduce Hospital Acquired Pressure Ulcers (HAPU).
Case Studies
Leading Practice: Reduction or Elimination of HAPU - University of Virginia Health System
AHRMM is developing a repository for leading and proven supply chain practices, case studies, and toolkits that are developed from a
Advisory
Statement on Pricing Transparency
AHRMM’s Issues & Legislative Committee issued the following Statement on Pricing Transparency approved by AHRMM Board of Directors:<
Guides/Reports
Crossing the Quality Chasm: A New Health System for the 21st Century